---
category: listing
circular_id: 9c4e3d3af0cac9e7
date: '2025-09-05'
description: NSE announces listing of Amanta Healthcare Limited equity shares effective
  September 9, 2025, with 38,829,351 shares at Rs. 126 issue price.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML70061.zip
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Standard IPO listing with significant share count but limited broader
  market impact
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML70061.zip
processing:
  attempts: 1
  content_hash: f31e47e1f1390c37
  processed_at: '2025-09-05T12:41:32.611942'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-09-05T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML70061.zip
severity: medium
source: nse
stocks:
- AMANTA
tags:
- ipo
- listing
- equity-shares
- new-listing
- healthcare
title: Listing of Equity Shares of Amanta Healthcare Limited (IPO)
---

## Summary

NSE announces the listing of equity shares of Amanta Healthcare Limited following its IPO. The company's shares will be available for trading on the Capital Market segment starting September 9, 2025, under the symbol AMANTA with ISIN INE084K01015.

## Key Points

- Company: Amanta Healthcare Limited
- Trading Symbol: AMANTA
- ISIN: INE084K01015
- Face Value: Rs. 10 per share
- Issue Price: Rs. 126 per share
- Total Securities: 38,829,351 equity shares
- Market Lot: 1 share
- Series: Initially BE, later shifted to EQ as per SEBI regulations

## Regulatory Changes

Shares will initially trade in Series 'BE' and subsequently be shifted to Series 'EQ' as per SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012.

## Compliance Requirements

- Securities will be part of pre-open session for IPO and Other category scrips
- Trading identification by designated codes only
- Lot sizes as specified in the annexure must be followed
- Lock-in periods apply as detailed in Annexure I with dates ranging from March 10-11, 2026

## Important Dates

- **Effective Date**: September 9, 2025
- **Lock-in Period Ends**: March 10-11, 2026 (varies by shareholder category)
- **Financial Year**: April 2025 - March 2026

## Impact Assessment

This is a standard IPO listing with moderate market impact. The healthcare sector addition provides investors with another option in the medical services space. The significant number of shares (38.8 million) and lock-in provisions suggest institutional and promoter participation, which could provide stability to the stock price in initial trading sessions.